Tirzepatide 30mg(Mangelo)(GLP-1) x 1Vial+Injection water ample

** Customers to Japan **

If there is a problem with the injectable at the counter, from 2020, you will be asked to propose proof of drug monitoring.

If you cannot prepare the drug monitoring proof, please proceed with the procedure to postpone it.

We will contact you when the product arrives, and we will resend it after you pay the shipping fee again.

*Please note that this product cannot be refunded after sales.

Tirzepatide 30mg (Mounjaro) (GLP-1) x 1 vial + water for injection

What is Tirzepatide (Mounjaro) for weight loss?

Tirzepatide (Mounjaro) stimulates insulin secretion by mimicking the GLP-1 and GIP hormones naturally secreted by the intestine after a meal. It also slows down gastric emptying time and suppresses appetite by interacting with the area of the brain that has the GLP-1 receptor that conveys the feeling of fullness.

Is there anyone who cannot take Tirzepatide?

People with kidney disease. People with gastrointestinal disorders. People with thyroid cancer or a family history of thyroid cancer. People with an unusual or allergic reaction to tirzepatide, other medicines, foods, dyes, or preservatives should always consult a doctor before use.

Can I take tirzepatide even if I don’t have diabetes?

Tirzepatide (Mounjaro, Zepbound) is a once-weekly injectable medication to lower blood sugar levels in people with type 2 diabetes. It is also FDA-approved for chronic weight management in adults with diabetes.

Is tirzepatide (Mounjaro) the same as Ozempic (semaglutide)?

A new analysis shows that tirzepatide (Mounjaro) is more effective than semaglutide in both blood sugar control and weight loss.

Weight loss treatment information

Weeks 1-4: 2.5mg/week
Weeks 5-8: 5mg/week
Weeks 9-12: 7.5mg/week
Weeks 13-16: 10mg/week
Weeks 17-20: 12.5mg/week
Weeks 21-24: 15mg/week

For first-time users, start with 2.5mg and increase every 4 weeks according to the increments in the table.